Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 05, 2007. The document serves as a notification of transactions involving directors and persons discharging managerial responsibility, specifically regarding changes in their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The only financial data present is the transaction price of GBP13.97 per Ordinary Share for a Single Company ISA purchase on January 04, 2007.
Material Changes
There are no material changes to the company's financial position or operations reported in this document. The filing details specific share purchases by two individuals:
- Mr J S Heslop: 5 Ordinary Shares
- Mr A P Witty: 4 Ordinary Shares
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, outlook, risk factors, contingencies, or unusual items. It is strictly a regulatory disclosure of director share transactions in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Investor Verification Points
- Verify the total number of shares held by Mr J S Heslop and Mr A P Witty post-transaction.
- Confirm the market price of GSK Ordinary Shares on January 04, 2007, against the reported purchase price of GBP13.97.
- Review subsequent filings for any further director transactions or changes in beneficial ownership.